PITPNC1 Suppress CD8+ T cell immune function and promote radioresistance in rectal cancer by modulating FASN/CD155
Abstract Background Radioresistance is a primary factor contributing to the failure of rectal cancer treatment. Immune suppression plays a significant role in the development of radioresistance. We have investigated the potential role of phosphatidylinositol transfer protein cytoplasmic 1 (PITPNC1)...
Main Authors: | Junxian Liang, Limin Liao, Lang Xie, WenWen Tang, Xiang Yu, Yinghao Lu, Hongzhen Chen, Juanli Xu, Lei Sun, Huanmei Wu, Chunhui Cui, Yujing Tan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-024-04931-3 |
Similar Items
-
Radioresistance in rectal cancer: can nanoparticles turn the tide?
by: Diogo Coelho, et al.
Published: (2025-01-01) -
MODERN RADIOTHERAPY REGIMENS AND BIOMARKERS OF RADIORESISTANT RECTAL TUMOR CELLS
by: N. G. Vasilchenko, et al.
Published: (2020-01-01) -
SREBP1/FASN/cholesterol axis facilitates radioresistance in colorectal cancer
by: Yuxiao Jin, et al.
Published: (2021-05-01) -
Artemis as Predictive Biomarker of Responsiveness to Preoperative Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer
by: Hai Liu, et al.
Published: (2024-01-01) -
LncRNA HOTAIRM1 promotes radioresistance in nasopharyngeal carcinoma by modulating FTO acetylation-dependent alternative splicing of CD44
by: Jinglin Mi, et al.
Published: (2024-10-01)